Velpanat Sofosbuvir Velpatasvir Tablet

Velpanat Sofosbuvir and Velpatasvir Tablet is a prescription antiviral medication used in the treatment of chronic hepatitis C virus (HCV) infection across multiple genotypes. It contains Sofosbuvir and Velpatasvir, two direct-acting antiviral agents that work together to prevent the hepatitis C virus from multiplying and spreading within the body. By reducing viral load and helping eliminate the infection, Velpanat Tablet supports improved liver health and lowers the risk of complications such as cirrhosis, liver failure, and liver cancer. Taken orally as prescribed by a healthcare professional, it is commonly used as a complete treatment regimen for eligible patients with chronic hepatitis C. Regular monitoring of liver function and viral response is important during therapy to ensure optimal treatment outcomes. Patients should use Velpanat Sofosbuvir and Velpatasvir Tablet only under the guidance of their healthcare provider.